DRUG DEALER SENTENCED TO 8 YEARS IN FEDERAL PRISON FOR ROLE IN FENTANYL DEATH OF YAMHILL COUNTY TEEN

U.S. Attorney's Office - District of Oregon

PORTLAND, Ore.—An Oregon man was sentenced to federal prison Tuesday for distributing counterfeit pills containing fentanyl that caused the fatal overdose of a Yamhill County teen.

Dylan Wilson, 26, of Lafayette, Oregon, was sentenced to 96 months in federal prison and three years’ supervised release.

According to court documents, on July 21, 2021, Yamhill County Sheriff’s Office deputies responded to the fatal overdose of a 15-year-old in Dayton, Oregon. A search of the victim’s cell phone and an interview with one of the victim’s minor friends revealed that the victim had recently purchased what they thought were Oxycodone pills from Wilson. The victim was not aware that the counterfeit pills, labeled with “M30,” contained fentanyl. A toxicology report later confirmed the victim died of a fentanyl overdose.

The next day, on July 22, 2021, Yamhill County deputies and FBI special agents surveilled Wilson’s residence in Lafayette and arrested him without incident. Wilson confessed to knowing the victim was a minor before selling the counterfeit pills. A search of Wilson’s cell phone revealed evidence of his fentanyl supplier. Investigators identified the supplier as Scott Keeling, 23, of McMinnville, Oregon, and arrested Keeling the same day.

On December 7, 2021, a federal grand jury in Portland returned a three-count indictment charging Wilson and Keeling with conspiring with one another and others to possess with intent to distribute fentanyl and possessing with intent to distribute fentanyl.

On February 21, 2023, Keeling pleaded guilty to possessing with intent to distribute fentanyl. Two months later, on April 5, 2023, Wilson pleaded guilty to the same charge. On May 30, 2023, Keeling was sentenced to 96 months in federal prison and three years’ supervised release.

This case was investigated by the Yamhill County Sheriff’s Office and the FBI. It was prosecuted by the U.S. Attorney’s Office for the District of Oregon.



Comments